BioCentury
ARTICLE | Politics, Policy & Law

Woodcock’s appointment as acting FDA commissioner could be audition for permanent position

Woodcock will focus on COVID-19 response and restoring FDA’s strength as Biden decides if she, Joshua Sharfstein, or someone else should lead the agency

January 16, 2021 2:13 AM UTC

Politics, Policy & Law

When Janet Woodcock moves into the FDA commissioner’s office next week, she will take charge, at least on an acting basis, of an agency that has been pummeled for months. President Donald Trump’s attacks on FDA’s independence and credibility have sapped staff morale while ideologically motivated actions taken by HHS leadership threaten to undermine FDA’s ability to carry out critical tasks. ...